IP Library › Patent Application 18185936
Patent Application Utility
App. No. 18/185,936 · Confirmation No. 5159

SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHODS OF USE

Applicant: Kura Oncology, Inc.
Abandoned -- Incomplete Application (Pre-examination)
⬇ PDF
 Code Description Pages PDF
2024-01-17 ABN Abandonment 2 View
2023-12-18 N417.PYMT Electronic Fee Payment 2 View
2023-12-18 N417 Electronic Filing System Acknowledgment Receipt 2 View
2023-12-18 XT/ Extension of Time 1 View
2023-05-18 APP.FILE.REC Filing Receipt 4 View
2023-05-18 WCLM Claims Worksheet (PTO-2022) 2 View
2023-05-18 WFEE Fee Worksheet (SB06) 1 View
2023-05-18 NTC.MISS.PRT Notice to File Missing Parts 2 View
2023-03-17 CRFE Sequence Listing in Computer Readable Format, No errors found — View
2023-03-17 SPEC Specification — View
2023-03-17 TRNA Transmittal of New Application 2 View
2023-03-17 N417 Electronic Filing System Acknowledgment Receipt 3 View
2023-03-17 SPEC Specification 167 View
2023-03-17 CLM Claims 22 View
2023-03-17 ABST Abstract 1 View
2023-03-17 ADS Application Data Sheet 9 View
2023-03-17 DRW Drawings-only black and white line drawings 3 View
2023-03-17 OATH Oath or Declaration filed 3 View
2023-03-17 SEQ.XML Sequence Listing (XML File) 1 View
2023-03-17 CRFE Sequence Listing in Computer Readable Format, No errors found 5 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
18/185,936
Filed
2023-03-17